Circular RNA hsa_circ_0004015 regulates the proliferation, invasion, and TKI drug resistance of non-small cell lung cancer by miR-1183/PDPK1 signaling pathway

被引:106
作者
Zhou, You [1 ,2 ,3 ]
Zheng, Xiao [1 ,2 ,3 ]
Xu, Bin [1 ,2 ,3 ]
Chen, Lujun [1 ,2 ,3 ]
Wang, Qi [1 ,2 ,3 ]
Deng, Haifeng [1 ,2 ,3 ]
Jiang, Jingting [1 ,2 ,3 ]
机构
[1] Soochow Univ, Affiliated Hosp 3, Dept Tumor Biol Treatment, Juqian Rd 185, Changzhou 213003, Peoples R China
[2] Jiangsu Engn Res Ctr Tumor Immunotherapy, Changzhou 213003, Peoples R China
[3] Soochow Univ, Inst Cell Therapy, Changzhou 213003, Peoples R China
基金
中国国家自然科学基金;
关键词
Non-small cell lung cancer; hsa_circ_0004015; miR-1183; 3-Phosphoinositide dependent protein; kinase-1; BIOMARKER; PROFILE;
D O I
10.1016/j.bbrc.2018.11.157
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Circular RNAs (circRNAs) were recently reported to be involved in the pathogenesis of Non-small cell lung cancer (NSCLC), however, the molecular mechanisms of circRNAs in cell proliferation, invasion and TKI drug resistance remain largely undetermined. Here, we identified hsa_circ_0004015 was upregulated in NSCLC tissues, and was associated with the poor overall survival rate of NSCLC patients. Knockdown of hsa_circ_0004015 significantly decreased cell viability, proliferation, and invasion, whereas over-expression exhibited opposed effects in vivo and in vitro. Furthermore, hsa_circ_0004015 could enhance the resistance of HCC827 to gefitinib. In mechanism, hsa_circ_0004015 acted as a sponge for miR-1183, and PDPK1 was revealed to be target gene of miR-1183. Subsequently, functional assays illustrated that the oncogenic effects of hsa_circ_0004015 was attributed to the regulation of miR-1183/PDPK1 axis. In conclusion, circ_0016760/miR-1183/PDPK1 signaling pathway might play vital roles in the tumorigenesis of NSCLC. (C) 2018 Elsevier Inc. All rights reserved.
引用
收藏
页码:527 / 535
页数:9
相关论文
共 26 条
[1]   Regulatory network of circRNA-miRNA-mRNA contributes to the histological classification and disease progression in gastric cancer [J].
Cheng, Jia ;
Zhuo, Huiqin ;
Xu, Mao ;
Wang, Linpei ;
Xu, Hao ;
Peng, Jigui ;
Hou, Jingjing ;
Lin, Lingyun ;
Cai, Jianchun .
JOURNAL OF TRANSLATIONAL MEDICINE, 2018, 16
[2]   Hsa_circ_0033155: A potential novel biomarker for non-small cell lung cancer [J].
Gu, Xiaohua ;
Wang, Gang ;
Shen, Hui ;
Fei, Xiaoyun .
EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2018, 16 (04) :3220-3226
[3]   A consensus on the role of osimertinib in non-small cell lung cancer from the AME Lung Cancer Collaborative Group [J].
Jiang, Tao ;
Su, Chunxia ;
Ren, Shengxiang ;
Cappuzzo, Federico ;
Rocco, Gaetano ;
Palmer, Joshua D. ;
van Zandwijk, Nico ;
Blackhall, Fiona ;
Le, Xiuning ;
Pennell, Nathan A. ;
Zhou, Caicun .
JOURNAL OF THORACIC DISEASE, 2018, 10 (07) :3909-3921
[4]   EGFR inhibitor and chemotherapy combinations for acquired TKI resistance in EGFR-mutant NSCLC models [J].
Laurila, Niina ;
Koivunen, Jussi P. .
MEDICAL ONCOLOGY, 2015, 32 (07)
[5]   Loss of PDPK1 abrogates resistance to gemcitabine in label-retaining pancreatic cancer cells [J].
Li, Dandan ;
Mullinax, John E. ;
Aiken, Taylor ;
Xin, Hongwu ;
Wiegand, Gordon ;
Anderson, Andrew ;
Thorgeirsson, Snorri ;
Avital, Itzhak ;
Rudloff, Udo .
BMC CANCER, 2018, 18
[6]   Upregulated circular RNA circ_0016760 indicates unfavorable prognosis in NSCLC and promotes cell progression through miR-1287/GAGE1 axis [J].
Li, Yongsheng ;
Hu, Jiahang ;
Li, Lijuan ;
Cai, Shengyan ;
Zhang, Hengchun ;
Zhu, Xianfeng ;
Guan, Guijie ;
Dong, Xiangmei .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2018, 503 (03) :2089-2094
[7]   Advances in the use of motion management and image guidance in radiation therapy treatment for lung cancer [J].
Molitoris, Jason K. ;
Diwanji, Tejan ;
Snider, James W., III ;
Mossahebi, Sina ;
Samanta, Santanu ;
Badiyan, Shahed N. ;
Simone, Charles B., II ;
Mohindra, Pranshu .
JOURNAL OF THORACIC DISEASE, 2018, 10 :S2437-S2450
[8]  
Qin HF, 2018, AM J TRANSL RES, V10, P2234
[9]   Circular RNA: A new star of noncoding RNAs [J].
Qu, Shibin ;
Yang, Xisheng ;
Li, Xiaolei ;
Wang, Jianlin ;
Gao, Yuan ;
Shang, Runze ;
Sun, Wei ;
Dou, Kefeng ;
Li, Haimin .
CANCER LETTERS, 2015, 365 (02) :141-148
[10]   Circular RNA Signature Predicts Gemcitabine Resistance of Pancreatic Ductal Adenocarcinoma [J].
Shao, Feng ;
Huang, Mei ;
Meng, Futao ;
Huang, Qiang .
FRONTIERS IN PHARMACOLOGY, 2018, 9